Clinical Data A 25-year-old female patient was admitted to our hospital on September 4, 2019, with “fever for 3 days and chest tightness and shortness of breath for 2 days”. She had no previous history of coronary heart disease or hypertension. Three days before admission, she developed chills, low-grade fever, dry cough, and clear nasal discharge after catching a cold. Two days before admission, she experienced chest tightness and shortness of breath after mild physical activity, which relieved after rest. Admission physical examination: Temperature 37.3 ℃, blood pressure 85/55 mmHg, clear consciousness, poor mental state, pale complexion, respiratory rate 27 breaths/min, heart rate 108 beats/min, regular rhythm, no murmurs. Abdomen (-), no edema of lower extremities. Admission ECG: Sinus rhythm; ST segment elevation of 0.1–0.3 mv in leads II, III, aVF, V1-V6, and pathological Q waves in leads II, III, aVF. Initial diagnosis after admission: Fulminant myocarditis? Acute ST-segment elevation myocardial infarction (to be excluded). Laboratory tests on admission: D-dimer: 0.45 mg/L, B-type natriuretic peptide (BNP): 7401.8 pg/mL, high-sensitivity troponin I (cTnI): 11.41 ng/mL; creatine kinase isoenzyme (CK-MB): 59.2 ng/mL, myoglobin: 132.5 ng/mL; total white blood cell count: 3.74 × 109/L; hemoglobin: 125 g/L, C-reactive protein (CRP): 19 mg/L, erythrocyte sedimentation rate (ESR): 24 mm/1 h, procalcitonin: 0.07 ng/mL. Blood gas analysis (without oxygen inhalation): pH value: 7.403; partial pressure of carbon dioxide: 31.60 mmHg; partial pressure of oxygen: 45.50 mmHg; blood oxygen saturation: 79.00%; blood lactic acid (lac): 2.3 mmol/L. Transthoracic echocardiography showed: Left atrial diameter 31 mm, left ventricular diameter 35 mm, right atrial diameter 31 mm, right ventricular diameter 23 mm, interventricular septum 13 mm, left ventricular ejection fraction (LVEF) 60%. Chest CT plain scan: No exudative lesions in both lungs. Coronary CTA: No coronary artery stenosis. Cardiac magnetic resonance imaging (MRI): Normal diameters of each cardiac chamber, normal left ventricular function, no definite myocardial fibrosis or edema.
Trachtenberg B, Hare J, 2017, Inflammatory Cardiomyopathic Syndromes. Circulation Research, 121(7): 803–818.
Sun D, Ding H, Zhao C, et al., 2017, Value of SOFA, APACHE IV and SAPS II Scoring Systems in Predicting Short-Term Mortality in Patients with Acute Myocarditis. Oncotarget. 8(38):63073–63083.
Lin X, Sun Y, Jing Z, et al., 2021, Myocarditis and Inflammatory Cardiomyopathy: In-Depth Understanding of Pathological Mechanisms and Continuous Improvement of Diagnosis and Treatment. Chinese Journal of Cardiology, 2021(1): 6–10.
Precision Medicine Group of Chinese Society of Cardiology, Editorial Board of Chinese Journal of Cardiology, 2017, Chinese Expert Consensus on Diagnosis and Treatment of Adult Fulminant Myocarditis. Journal of Internal Intensive Medicine, 2017(6): 443–452.
Wang Y, Yuan Y, Wang Q, et al., 2017, Clinical Analysis of 64 Children with Fulminant Myocarditis. Journal of Internal Intensive Medicine, 2017(6): 935–937.
Li L, Han B, 2024, Research Progress in Etiology and Treatment of Myocarditis. Clinical Misdiagnosis and Mistherapy, 37(19): 94–100.
Xiao Q, Wei X, Wang S, et al., 2021, Early Diagnosis and Diagnostic Process of Fulminant Myocarditis. Chinese Journal of Cardiovascular Research, 19(2): 159–163.
Dennert R, Crijns H, Heymans S, et al., 2008, Acute Viral Myocarditis. Chinese Journal of Cardiovascular Medicine, 2008(5): 394–398.
Chen W, Zhang H, Guo Y, et al., 2019, Treatment Strategies and Prognosis of Biopsy-Proven Viral Myocarditis. Advances in Cardiovascular Diseases, 40(5): 813–817.
Ainur M, Yuan J, Chen R, et al., 2025, A Case of Fulminant Myocarditis Related to Tislelizumab Diagnosed by Myocardial Biopsy. Chinese Circulation Journal, 40(3): 293–296.
Lin M, 2025, Viral Myocarditis. Journal of Chinese Electron Microscopy Society, 44(1): 1–9.
Xu Y, Qian J, Ge J, 2024, Tracing the Root Cause of a Patient with Acute Heart Failure and Myocardial Hypertrophy: A Case Report. China Clinical Case Registry, 6(1): E0864–E0864.
Mo R, Chang X, Ma F, et al., 2024, Nursing Care of 18 Tumor Patients with Severe Immune Checkpoint Inhibitor-Related Myocarditis. Journal of Nursing, 31(8): 60–62.
Ainur M, Yuan J, Chen R, et al., 2025, A Case of Fulminant Myocarditis Related to Tislelizumab Diagnosed by Myocardial Biopsy. Chinese Circulation Journal, 40(3): 293–296.
Li L, Han B, 2024, Research Progress in Etiology and Treatment of Myocarditis. Clinical Misdiagnosis and Mistherapy, 37(19): 94–100.